Cambridge Cognition (LON:COG) Trading Up 6.3% – What’s Next?

Cambridge Cognition Holdings Plc (LON:COG)’s share price shot up 6.3% on Friday . The stock traded as high as GBX 37.24 ($0.47) and last traded at GBX 36.15 ($0.45). 223,769 shares were traded during trading, an increase of 268% from the average session volume of 60,742 shares. The stock had previously closed at GBX 34 ($0.43).

Cambridge Cognition Stock Up 6.3 %

The business has a fifty day moving average price of GBX 28.95 and a two-hundred day moving average price of GBX 36.58. The firm has a market capitalization of £15.16 million, a price-to-earnings ratio of -903.75 and a beta of 0.72. The company has a debt-to-equity ratio of 92.53, a current ratio of 0.65 and a quick ratio of 0.96.

Insider Transactions at Cambridge Cognition

In related news, insider Nick (Philip) Rodgers purchased 31,292 shares of Cambridge Cognition stock in a transaction that occurred on Monday, December 23rd. The stock was bought at an average cost of GBX 32 ($0.40) per share, for a total transaction of £10,013.44 ($12,548.17). Also, insider Stuart Gall acquired 31,250 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average cost of GBX 32 ($0.40) per share, for a total transaction of £10,000 ($12,531.33). Company insiders own 29.89% of the company’s stock.

About Cambridge Cognition

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.